Arena Pharmaceuticals (ARNA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
12-2021 | 12-2020 | 12-2019 | 12-2018 | 12-2017 | |
Assets | |||||
Current Assets | |||||
Cash & Cash Equivalents | 224,572 | 219,544 | 243,274 | 161,037 | 158,837 |
Marketable Securities | 325,897 | 884,497 | 496,291 | 284,594 | 88,240 |
Receivables | N/A | N/A | N/A | 5,086 | 14,382 |
Other current assets | 0 | 0 | 0 | 0 | 17,140 |
TOTAL | $569,465 | $1,139,307 | $759,934 | $460,725 | $281,280 |
Non-Current Assets | |||||
PPE Net | 19,125 | 22,090 | 25,128 | 23,114 | 30,131 |
Investments And Advances | 160,796 | 0 | 370,938 | 82,412 | 24,242 |
Other Non-Current Assets | 35,319 | 29,323 | 18,123 | 120,652 | 3,622 |
TOTAL | $215,240 | $51,413 | $414,189 | $226,178 | $57,995 |
Total Assets | $784,705 | $1,190,720 | $1,174,123 | $686,903 | $339,275 |
Liabilities | |||||
Current Liabilities | |||||
Accounts payable and accrued liabilities | 32,135 | 35,351 | 25,499 | 16,181 | 7,916 |
Accrued Expenses | 29,129 | 18,325 | 15,654 | 10,454 | 31,706 |
Other current liabilities | N/A | N/A | N/A | N/A | 27,595 |
TOTAL | $66,316 | $58,077 | $44,967 | $29,918 | $72,327 |
Non-Current Liabilities | |||||
Deferred Revenues | N/A | N/A | N/A | N/A | 1,110 |
Other Non-Current Liabilities | 8,993 | 10,963 | 12,078 | 1,301 | 2,314 |
TOTAL | $45,152 | $52,174 | $57,691 | $50,727 | $59,804 |
Total Liabilities | $111,468 | $110,251 | $102,658 | $80,645 | $132,131 |
Shareholders' Equity | |||||
Shares Outstanding, K | 61,659 | 60,335 | 50,249 | 49,463 | 39,402 |
Common Shares | 6 | 6 | 5 | 5 | 4 |
Retained earnings | -2,124,164 | -1,507,731 | -1,102,997 | -1,500,552 | -1,490,187 |
Other shareholders' equity | -280 | 700 | 1,303 | -155 | -1,216 |
TOTAL | $673,237 | $1,080,469 | $1,071,465 | $606,258 | $207,144 |
Total Liabilities And Equity | $784,705 | $1,190,720 | $1,174,123 | $686,903 | $339,275 |